Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy
The Lymphoma Academic Research Organisation
The Lymphoma Academic Research Organisation
City of Hope Medical Center
M.D. Anderson Cancer Center
Peking University Third Hospital
University of Washington
Fondazione Italiana Linfomi - ETS
The Lymphoma Academic Research Organisation
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
The Lymphoma Academic Research Organisation
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
The Lymphoma Academic Research Organisation
Masonic Cancer Center, University of Minnesota
Fondazione Italiana Linfomi - ETS
M.D. Anderson Cancer Center
Mayo Clinic
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
H. Lee Moffitt Cancer Center and Research Institute
Ruijin Hospital
Fondazione Italiana Linfomi - ETS
University of Utah
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
University of Washington
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
University of California, San Francisco
University of Washington
Tianjin Medical University Cancer Institute and Hospital
Ruijin Hospital
PrECOG, LLC.
Insel Gruppe AG, University Hospital Bern
University of Miami
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Weill Medical College of Cornell University
Fred Hutchinson Cancer Center
Sun Yat-sen University
Masonic Cancer Center, University of Minnesota